Spatial analysis of NOS2, COX2 and CD8 expression in patient tumors has identified mechanisms of treatment inhibition that were further elucidated using the 4T1 mouse model of triple negative breast cancer and live cell culture studies. This evidence concerns the gene PTGS2 and triple-negative breast carcinoma.